Literature DB >> 33440209

Dissecting the anti-biofilm potency of kappa-carrageenan capped silver nanoparticles against Candida species.

Payal Gupta1, Apoorva Goel2, Khushboo Rani Singh1, Mukesh Kumar Meher1, Khushboo Gulati1, Krishna Mohan Poluri3.   

Abstract

Global antimicrobial crisis and advent of drug resistant fungal strains has substantially distressed disease management for clinicians. Biodegradable silver nanoparticles (AgNps) emerge as an excellent alternative remedial option. In the current study, the anti-biofilm activity of microwave irradiated kappa-carrageenan (CRG) capped AgNps against Candida albicans, and Candida glabrata was investigated in terms of their effect on reactive oxygen species (ROS) generation, cellular morphology, biochemical composition, and the activity of enzymes of extracellular matrix. Minimum inhibitory concentration and fungicidal concentration value of CRG-AgNps against both Candida spp. ranged between 400 and 500 μg/mL. The 80% of Candida biofilm was inhibited and eradicated by CRG-AgNps at a concentration of ~300 μg/mL. Microscopic studies indicate that CRG-AgNps caused morphological damage through membrane disruption and pore formation. Further, CRG-AgNps generated ROS in a concentration-dependent manner and modulated the composition of Candida biofilm ECM by increasing the carbohydrate and eDNA content. CRG-AgNps also significantly inactivated the hydrolytic enzymes, thus hindering the biofilm forming ability. In conclusion, all these results suggest that the CRG-AgNps are potential antifungal agents against Candida biofilms, and they inhibit/eradicate the fungal biofilms through multiple signalling mechanisms.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial agents; Candida; Fungal biofilm; Kappa carrageenan; Reactive oxygen species; Silver nanocomposites

Mesh:

Substances:

Year:  2021        PMID: 33440209     DOI: 10.1016/j.ijbiomac.2021.01.035

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  3 in total

1.  Molecular investigations on Candida glabrata clinical isolates for pharmacological targeting.

Authors:  Hrishikesh Gupta; Payal Gupta; Manikyaprabhu Kairamkonda; Krishna Mohan Poluri
Journal:  RSC Adv       Date:  2022-06-14       Impact factor: 4.036

2.  Geraniol eradicates Candida glabrata biofilm by targeting multiple cellular pathways.

Authors:  Payal Gupta; Hrishikesh Gupta; Krishna Mohan Poluri
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-01       Impact factor: 4.813

3.  Inhibition of Candida glabrata Biofilm by Combined Effect of Dendritic Compounds and Amphotericin.

Authors:  Natalia Gómez-Casanova; Alba Torres-Cano; Alba Xiaohe Elias-Rodriguez; Tania Lozano; Paula Ortega; Rafael Gómez; Jorge Pérez-Serrano; José Luis Copa-Patiño; Irene Heredero-Bermejo
Journal:  Pharmaceutics       Date:  2022-07-31       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.